M V Ortega1,2, Y Kim1,2, K Hung1,2, K James1,3, L Savitt4, E Von Bargen1,2, L G Bordeianou4, M M Weinstein5,6. 1. Division of Female Pelvic Medicine and Reconstructive Surgery, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. 2. Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA, USA. 3. Deborah Kelly Center for Outcomes Research, Massachusetts General Hospital, Boston, MA, USA. 4. Division of General and Gastrointestinal Surgery, Section of Colon and Rectal Surgery, Department of Surgery, General Hospital, Boston, MA, USA. 5. Division of Female Pelvic Medicine and Reconstructive Surgery, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. mweinstein2@mgh.harvard.edu. 6. Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA, USA. mweinstein2@mgh.harvard.edu.
Abstract
BACKGROUND: The aim of our study was to characterize urogenital symptoms in women with and without constipation, and by severity of constipation. METHODS: This was a retrospective cohort study conducted at a pelvic floor disorder center in a tertiary healthcare facility from May 2007 through August 2019 and completed an intake questionnaire were included. We collected demographic, physical exam data and quality of life outcomes. The Urinary Distress Inventory (UDI-6) was used to assess urogenital symptoms. Women with constipation completed the Constipation Severity Instrument (CSI). We excluded women with a history of a bowel resection, inflammatory bowel disease, or pelvic organ prolapse symptoms. The cohort was then divided into two groups, constipated and non-constipated, and the prevalence and severity of urogenital-associated symptoms were compared. A secondary analysis was made among constipated subjects stratified by constipation severity based on CSI scores. RESULTS: During the study period, 875 women (59.5%) had chronic constipation. Women with chronic constipation were more likely to experience urogenital symptoms, such as dyspareunia, urinary hesitancy, and a sensation of incomplete bladder emptying (all p < 0.05). Moreover, on univariate analysis, women with high CSI scores (75 percentile or higher) were found to have higher UDI-6 scores, increased bladder splinting, pad use, urinary frequency and dyspareunia while on multivariate analysis higher UDI score, increased bladder splinting, urinary frequency and dyspareunia were significantly associated (p < 0.05). CONCLUSION: We found that the presence and severity of chronic constipation worsened the degree of bother from urogenital symptoms. Given that chronic constipation can modulate urogenital symptoms, our study suggests that pelvic floor specialists should assess the presence and severity of urogenital and bowel symptoms to provide comprehensive care.
BACKGROUND: The aim of our study was to characterize urogenital symptoms in women with and without constipation, and by severity of constipation. METHODS: This was a retrospective cohort study conducted at a pelvic floor disorder center in a tertiary healthcare facility from May 2007 through August 2019 and completed an intake questionnaire were included. We collected demographic, physical exam data and quality of life outcomes. The Urinary Distress Inventory (UDI-6) was used to assess urogenital symptoms. Women with constipation completed the Constipation Severity Instrument (CSI). We excluded women with a history of a bowel resection, inflammatory bowel disease, or pelvic organ prolapse symptoms. The cohort was then divided into two groups, constipated and non-constipated, and the prevalence and severity of urogenital-associated symptoms were compared. A secondary analysis was made among constipated subjects stratified by constipation severity based on CSI scores. RESULTS: During the study period, 875 women (59.5%) had chronic constipation. Women with chronic constipation were more likely to experience urogenital symptoms, such as dyspareunia, urinary hesitancy, and a sensation of incomplete bladder emptying (all p < 0.05). Moreover, on univariate analysis, women with high CSI scores (75 percentile or higher) were found to have higher UDI-6 scores, increased bladder splinting, pad use, urinary frequency and dyspareunia while on multivariate analysis higher UDI score, increased bladder splinting, urinary frequency and dyspareunia were significantly associated (p < 0.05). CONCLUSION: We found that the presence and severity of chronic constipation worsened the degree of bother from urogenital symptoms. Given that chronic constipation can modulate urogenital symptoms, our study suggests that pelvic floor specialists should assess the presence and severity of urogenital and bowel symptoms to provide comprehensive care.
Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein Journal: Urology Date: 2003-01 Impact factor: 2.649
Authors: Alexander C Ford; Paul Moayyedi; Brian E Lacy; Anthony J Lembo; Yuri A Saito; Lawrence R Schiller; Edy E Soffer; Brennan M R Spiegel; Eamonn M M Quigley Journal: Am J Gastroenterol Date: 2014-08 Impact factor: 10.864
Authors: Ian M Paquette; Madhulika Varma; Charles Ternent; Genevieve Melton-Meaux; Janice F Rafferty; Daniel Feingold; Scott R Steele Journal: Dis Colon Rectum Date: 2016-06 Impact factor: 4.585
Authors: Liliana G Bordeianou; Jennifer T Anger; Marylise Boutros; Elisa Birnbaum; Joseph C Carmichael; Kathleen A Connell; Elise J B De; Anders Mellgren; Kyle Staller; Sarah A Vogler; Milena M Weinstein; Faysal A Yafi; Tracy L Hull Journal: Female Pelvic Med Reconstr Surg Date: 2020 Jan/Feb Impact factor: 2.091
Authors: Regula Doggweiler; Kristene E Whitmore; Jane M Meijlink; Marcus J Drake; Helena Frawley; Jørgen Nordling; Philip Hanno; Matthew O Fraser; Yukio Homma; Gustavo Garrido; Mario J Gomes; Sohier Elneil; Joop P van de Merwe; Alex T L Lin; Hikaru Tomoe Journal: Neurourol Urodyn Date: 2016-08-26 Impact factor: 2.696
Authors: Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer Journal: Int Urogynecol J Date: 2009-11-25 Impact factor: 2.894
Authors: Madhulika G Varma; Jennifer Y Wang; Julia R Berian; Taryn R Patterson; G Lindsay McCrea; Stacey L Hart Journal: Dis Colon Rectum Date: 2008-01-03 Impact factor: 4.585
Authors: Fermín Mearin; Brian E Lacy; Lin Chang; William D Chey; Anthony J Lembo; Magnus Simren; Robin Spiller Journal: Gastroenterology Date: 2016-02-18 Impact factor: 22.682